Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
This system demonstrated exceptional adaptability, stability, and robustness in monitoring the growth kinetics of six common pathogenic bacteria
Cardiovascular disease in transplant recipients: current and future treatment strategies
The reasons are specific and addressable when identified early in the protocol
Certificates of Analysis are available to support transparency and reproducibility in experimental workflows
People with a history of medullary thyroid carcinoma, MEN2, pancreatitis, pregnancy, or severe GI disorders are not ideal candidates
3.5 Preclinical (15 programs) ASC37 (Ascletis Pharma) - peptide in both oral tablet and once-monthly subcutaneous formulations
US$ 27.21
US$ 29.18
US$ 29.37
US$ 21.40
US$ 29.91
US$ 27.47
US$ 21.24
US$ 26.17
